Michele Diegman

Title: Michele Diegman: Innovator in Bone Graft Technology

Introduction

Michele Diegman is a notable inventor based in Scotch Plains, NJ (US). He has made significant contributions to the field of bone graft technology, holding 2 patents that focus on improving the efficacy of demineralized bone matrices.

Latest Patents

Diegman's latest patents include a bone graft comprising a demineralized bone matrix and a stabilizing agent. This innovative composition is designed to protect osteoinductive factors from degradation by enzymes at the implantation site. The stabilizing agents used can be biodegradable materials such as starches, cellulose, and collagen. As these agents degrade in vivo, they activate osteoinductive factors like TGF-β, BMP, and IGF, which are crucial for recruiting cells to the injury site and promoting bone formation. The invention also outlines methods for preparing, testing, and utilizing these improved osteoinductive matrix compositions.

Career Highlights

Throughout his career, Michele Diegman has worked with prominent companies in the medical field, including Osteotech, Inc. and Warsaw Orthopedic, Inc. His work has significantly impacted the development of advanced bone graft materials.

Collaborations

Diegman has collaborated with notable professionals in his field, including David Knaack and Kathy Traianedes, who have contributed to his research and innovations.

Conclusion

Michele Diegman's work in bone graft technology exemplifies the importance of innovation in medical science. His patents reflect a commitment to improving patient outcomes through advanced materials and methods.